Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

Agilent Technologies

A Healthcare Unknown Updated July 11, 2026
$134.31
52W $108.35 – $160.27
63/100
$41419.88T
26.9
1.25
Price History (6M)
AI Committee Verdict
Buy
Conviction: Moderate · 67% agreement · 6 analysts
+1.9%
-0.0%
193.00:1
75%
Executive Summary
5 analysts weighed in with 80% agreement on a bullish lean. Growth Analyst: Quarter-over-quarter growth rate is ACCELERATING, not just positive. Overall recommendation: BUY.
Bull & Bear Case
Bull Case
  • Daily trend: uptrend.
  • Daily uptrend conflicts with weekly downtrend — buying against the higher timeframe trend is higher risk.
  • Bullish candlestick pattern(s) detected: Three White Soldiers.
  • Bullish candlestick patterns signal potential reversal or continuation of upside.
  • Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
  • MACD histogram is negative (-0.245) — bearish momentum.
  • Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
AI Investment Committee
Committee Consensus As of July 11, 2026
Overall Committee Score
63/100
Agreement
67%
Analysts
6
Conviction
Moderate
Growth Analyst bullish
85 / 100 · Low confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst neutral
54 / 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
64 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 10 articles, 14d)
Portfolio Manager bullish
75 / 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Open Full Terminal →
Technical Analysis
RSI (14)
61.2
Neutral
MACD Histogram
-0.245
Bearish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Mixed
Support
$134.29
Resistance
$136.90
Bollinger %B
0.79
Inside Bands
Price vs Moving Averages
EMA 9
$132.08 Above
EMA 21
$130.81 Above
EMA 50
$127.26 Above
EMA 200
$126.63 Above
Fundamental Analysis
Valuation
61
Growth
59
Profitability
1
Financial Health
100
Cash Flow
37
Valuation
P/E Ratio 26.9×
P/B Ratio 5.34×
PEG Ratio 1.19
Dividend Yield 0.01%
52W High $160.27
52W Low $108.35
Quality & Growth
ROE 19.3%
ROA 10.2%
Gross Margin 53.0%
Operating Margin 21.5%
Revenue Growth YoY
Debt / Equity 0.47
AI Fundamental Assessment
P/E ratio of 26.9 (moderate relative to a 15-40x range); Price-to-book of 5.3x; PEG ratio of 1.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.2%; Return on assets of 0.1%; Net margin of 0.2%; Gross margin of 0.5%; Current ratio of 2.10 (healthy short-term liquidity); Debt-to-equity of 0.47; Free cash flow margin of 0.9% (thin cash generation); Free cash flow per share is positive (4.44); Most recent quarter beat estimates by 3.8%; EPS growth accelerating (-14.5% -> +9.6% QoQ); Analyst estimates falling over recent quarters
Key Risks
  • MACD histogram is negative (-0.245) — bearish momentum.
  • Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full A Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime